Nieves Martinez Lago, Consultant Medical Oncologist at University Hospital Complex of Santiago de Compostela, shared a post on X about a paper by Jonas Willmann et al. published in JAMA Network Open:
“SBRT in oligometastatic CA
Systematic review and meta-analysis (2,074 pts; 29 studies)
- Systemic therapy–free survival (1–2y): ~70% overall
- Best outcomes: RCC (87%) and prostate (78%)
- Grade ≥3 AEs uncommon
- SBRT may be an option in selected patients.”
Title: Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer
Authors: Jonas Willmann, Camilla von Wachter, Ronja Zehnder, Edward Christopher Dee, Hanbo Chen, Lizza E. L. Hendriks, Jordi Remon, Sarah Baker, Michael Mayinger, Nicolaus Andratschke, Narek Shaverdian, Daniel R. Gomez, Umberto Ricardi, Robert Olson, Arjun Sahgal, Dirk De Ruysscher, Puneeth Iyengar, and Matthias Guckenberger
You can read the Full Article in JAMA Network Open.
More posts featuring Nieves Martinez Lago.
